Phathom Pharmaceuticals, Inc. (PHAT)
11.87
-1.18
(-9.04%)
USD |
NASDAQ |
May 15, 16:00
11.87
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Total Liabilities (Quarterly) : 642.08M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 859.67M |
| Ligand Pharmaceuticals, Inc. | 534.78M |
| Axsome Therapeutics, Inc. | 659.02M |
| Corcept Therapeutics, Inc. | 176.89M |
| Assertio Holdings, Inc. | 135.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 305.12M |
| Shareholders Equity (Quarterly) | -336.96M |
| Debt to Equity Ratio | -1.624 |
| Current Ratio | 2.212 |
| Net Debt Paydown Yield | 0.18% |